Blood-based testing for colorectal cancer screening

Area of Science:

• Oncology
• Gastroenterology
• Biomarker Discovery

Background:

• Colorectal cancer (CRC) is a leading cause of cancer death globally, with screening significantly improving survival rates.
• Current CRC screening methods face challenges with sub-optimal uptake among recommended populations.
• A simple, accessible blood test could enhance screening adherence for individuals hesitant about traditional methods.

Purpose of the Study:

• To review existing blood-based screening tests for colorectal cancer (CRC).
• To explore novel biomarkers for CRC detection nearing clinical application.
• To discuss expanded uses of blood tests in CRC management, including prognosis and surveillance.

Main Methods:

• Literature review of current and emerging blood-based CRC screening technologies.
• Analysis of specific tests like the ColonSentry™ mRNA expression panel and SEPT9 methylated DNA test.
• Exploration of biomarker applications in high-risk populations and disease surveillance.

Main Results:

• Several blood-based tests, including mRNA and methylated DNA panels, are available for CRC screening.
• Newer biomarkers show promise for improved clinical implementation in CRC detection.
• Blood tests have potential applications beyond screening, aiding in prognosis and monitoring.

Conclusions:

• Blood-based tests represent a promising strategy to increase colorectal cancer screening rates.
• Ongoing research into novel biomarkers will further enhance the utility of blood tests for CRC.
• Expanded applications of blood testing can improve comprehensive management for CRC patients and high-risk individuals.